Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Birrer

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Ovarian cancer: targeting the untargetableMichael J Birrer
Cancer Cell|July 16, 2015
Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian CancerWei Wei, Michael J Birrer
Gynecologic Oncology|March 18, 2010
Translational research in the Gynecologic Oncology Group: evaluation of ovarian cancer markers, profiles, and novel therapiesKathleen M Darcy, Michael J Birrer
Journal of the National Cancer Institute|February 3, 2016
Making a Difference: Distinguishing Two Primaries From Metastasis in Synchronous Tumors of the Ovary and UterusDon S Dizon, Michael J Birrer
Discovery Medicine|July 1, 2014
Advances in the diagnosis and treatment of uterine sarcomasDon S Dizon, Michael J Birrer
The Oncologist|March 30, 2018
Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and ExpectationsKathleen N Moore, Michael J Birrer
Current Oncology Reports|October 3, 2003
Biologic directed therapies in gynecologic oncologyJohn H Farley, Michael J Birrer
Cell Research|April 23, 2008
Genomic analysis of epithelial ovarian cancerJohn Farley, Laurent L Ozbun, Michael J Birrer
Oncogene|August 29, 2003
AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targetsVirna D Leaner, Ichiro Kinoshita, Michael J Birrer
Current Opinion in Oncology|August 15, 2013
Clear cell cancer of the ovaryRichard T Penson, Don S Dizon, Michael J Birrer
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Ovarian cancer: targeting the untargetableMichael J Birrer
Cancer Cell|July 16, 2015
Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian CancerWei Wei, Michael J Birrer
Gynecologic Oncology|March 18, 2010
Translational research in the Gynecologic Oncology Group: evaluation of ovarian cancer markers, profiles, and novel therapiesKathleen M Darcy, Michael J Birrer
Journal of the National Cancer Institute|February 3, 2016
Making a Difference: Distinguishing Two Primaries From Metastasis in Synchronous Tumors of the Ovary and UterusDon S Dizon, Michael J Birrer
Discovery Medicine|July 1, 2014
Advances in the diagnosis and treatment of uterine sarcomasDon S Dizon, Michael J Birrer
The Oncologist|March 30, 2018
Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and ExpectationsKathleen N Moore, Michael J Birrer
Current Oncology Reports|October 3, 2003
Biologic directed therapies in gynecologic oncologyJohn H Farley, Michael J Birrer
Cell Research|April 23, 2008
Genomic analysis of epithelial ovarian cancerJohn Farley, Laurent L Ozbun, Michael J Birrer
Oncogene|August 29, 2003
AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targetsVirna D Leaner, Ichiro Kinoshita, Michael J Birrer
Current Opinion in Oncology|August 15, 2013
Clear cell cancer of the ovaryRichard T Penson, Don S Dizon, Michael J Birrer
Pageof 23